1. Home
  2. CHMI vs RVPH Comparison

CHMI vs RVPH Comparison

Compare CHMI & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHMI
  • RVPH
  • Stock Information
  • Founded
  • CHMI 2012
  • RVPH 2006
  • Country
  • CHMI United States
  • RVPH United States
  • Employees
  • CHMI N/A
  • RVPH N/A
  • Industry
  • CHMI Real Estate Investment Trusts
  • RVPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • CHMI Real Estate
  • RVPH Health Care
  • Exchange
  • CHMI Nasdaq
  • RVPH Nasdaq
  • Market Cap
  • CHMI 92.0M
  • RVPH 88.0M
  • IPO Year
  • CHMI 2013
  • RVPH N/A
  • Fundamental
  • Price
  • CHMI $3.39
  • RVPH $2.09
  • Analyst Decision
  • CHMI Buy
  • RVPH Strong Buy
  • Analyst Count
  • CHMI 3
  • RVPH 5
  • Target Price
  • CHMI $5.00
  • RVPH $11.40
  • AVG Volume (30 Days)
  • CHMI 259.3K
  • RVPH 1.8M
  • Earning Date
  • CHMI 03-06-2025
  • RVPH 11-14-2024
  • Dividend Yield
  • CHMI 17.70%
  • RVPH N/A
  • EPS Growth
  • CHMI N/A
  • RVPH N/A
  • EPS
  • CHMI N/A
  • RVPH N/A
  • Revenue
  • CHMI N/A
  • RVPH N/A
  • Revenue This Year
  • CHMI N/A
  • RVPH N/A
  • Revenue Next Year
  • CHMI $27.78
  • RVPH N/A
  • P/E Ratio
  • CHMI N/A
  • RVPH N/A
  • Revenue Growth
  • CHMI N/A
  • RVPH N/A
  • 52 Week Low
  • CHMI $2.50
  • RVPH $0.60
  • 52 Week High
  • CHMI $3.99
  • RVPH $4.83
  • Technical
  • Relative Strength Index (RSI)
  • CHMI 71.05
  • RVPH 60.41
  • Support Level
  • CHMI $3.07
  • RVPH $1.78
  • Resistance Level
  • CHMI $3.52
  • RVPH $2.15
  • Average True Range (ATR)
  • CHMI 0.09
  • RVPH 0.15
  • MACD
  • CHMI 0.03
  • RVPH 0.02
  • Stochastic Oscillator
  • CHMI 78.95
  • RVPH 88.30

About CHMI Cherry Hill Mortgage Investment Corporation

Cherry Hill Mortgage Investment Corp operates as a real estate investment trust in the United States. It invests in residential mortgage assets to generate current yields and risk-adjusted total returns for its stockholders over the long term, primarily through dividend distributions and secondarily through capital appreciation. The company's reportable segments include investments in Residential mortgage-backed securities (RMBS), Investments in Servicing Related Assets, and All Others. It generates maximum revenue from the RMBS segment in the form of Interest income earned for servicing mortgage loans.

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.

Share on Social Networks: